Evidence-Based Medicine Guidelines
Imipenem-cilastatin for febrile neutropenic patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Imipenem-cilastatin for Febrile Neutropenic Patients." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455590/all/Imipenem_cilastatin_for_febrile_neutropenic_patients.
Imipenem-cilastatin for febrile neutropenic patients. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455590/all/Imipenem_cilastatin_for_febrile_neutropenic_patients. Accessed September 19, 2024.
Imipenem-cilastatin for febrile neutropenic patients. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455590/all/Imipenem_cilastatin_for_febrile_neutropenic_patients
Imipenem-cilastatin for Febrile Neutropenic Patients [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 September 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455590/all/Imipenem_cilastatin_for_febrile_neutropenic_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Imipenem-cilastatin for febrile neutropenic patients
ID - 455590
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455590/all/Imipenem_cilastatin_for_febrile_neutropenic_patients
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
